معرفی
Camilla S. Colding-Christensen is an Assistant Professor at the Novo Nordisk Foundation Center for Protein Research (CPR) within the Department of Biology at the University of Copenhagen's Faculty of Health and Medical Sciences. She works in the Duxin Group and Nielsen Group, focusing on proteomics and molecular biomedicine research.
Education:
- PhD in Molecular Biomedicine (2016) - University of Copenhagen, Department of Biology
- M.Sc. in Molecular Biomedicine (2012) - University of Copenhagen, BRIC
- B.Sc. in Molecular Biomedicine (2010) - University of Copenhagen, Department of Biology
Dr. Colding-Christensen's research primarily focuses on proteomics, molecular and cellular biology, with specific interests in genome stability, cell cycle regulation, DNA repair mechanisms, and DNA stress and damage responses. Her work centers on ubiquitin signaling and its role in cellular processes, developing novel mass spectrometry-based technologies to investigate ubiquitination in Xenopus Laevis egg extracts. She has made significant contributions to understanding how ubiquitin signaling pathways regulate DNA damage responses and maintain genome integrity.
Her publication record shows a strong trend in proteomics-based approaches to studying DNA damage response mechanisms, ubiquitin signaling, and genome stability. The research spans from fundamental molecular mechanisms to potential implications for diseases like cancer where these pathways are often dysregulated.
Dr. Colding-Christensen has been actively involved in teaching as a laboratory instructor for courses including Molecular Genetics and Almen Molekylær Biologi (General Molecular Biology). She has also contributed to academic service through committee work, including chairing a PhD Assessment Committee and organizing academic events such as the ENABLE symposium and BIO PhD Day.
Her laboratory work involves cutting-edge mass spectrometry technologies and proteomics methodologies for identification and quantification of post-translational modifications, particularly focusing on the complex ubiquitin signaling system. She collaborates with multiple research groups at the University of Copenhagen and internationally, as evidenced by her conference participation and co-authorship on significant publications in high-impact journals.
